• Login
  • Contact

lluh horiz rgb

  • Home
  • Faculty
  • Contact

Melanoma

LOCAL

Filename Size
An Adobe Acrobat file Intergroup-2-vs-4-cm-for-1-4-mm-Ann-Surg-Oncol-2001 70.3 KB
An Adobe Acrobat file Swedish-2-vs-5-cm-for-0.8-2-mm-Cancer-2000 88.08 KB
An Adobe Acrobat file WHO-1-vs-3-cm-for-0-2-mm-Sem-Surg-Oncol-1998 42.06 KB

NODAL STAGING

Filename Size
An Adobe Acrobat file ACOSOG-Z0020-JCO-2006-ILP-Melphalan-wwo-TNF 243.89 KB
An Adobe Acrobat file MSLT-1-NEJM-2006 287.4 KB
An Adobe Acrobat file MSLT-2-NEJM-2017 526.11 KB
An Adobe Acrobat file SSO-ASCO-Melanoma-SLNB-guidelines_JCO2012 109.58 KB
An Adobe Acrobat file WHO-Lancet-1998---ELND 286.36 KB

ADJUVANT TREATMENT

Filename Size
An Adobe Acrobat file Adjuvant-high-dose-IFNa-2b-Clin-Canc-Res-2004 297.18 KB
An Adobe Acrobat file Adjuvant-high-dose-ipilimumab-NEMJ-2016 315.59 KB
An Adobe Acrobat file Adjuvant-nodal-XRT-melanoma-Aussie-2012 290.92 KB
An Adobe Acrobat file EORTC-18991-Pegylated-IFNa-2b 235.82 KB

METASTATIC

Filename Size
An Adobe Acrobat file BRAF-MEK-inhibitor-BRAF-mutant-metastatic-melanoma-NEJM-2014 524.02 KB
An Adobe Acrobat file IL-2-Metastatic-Melanoma-JCO-1999 189.4 KB
An Adobe Acrobat file Ipilimumab-Metastatic-Melanoma-NEJM-2011 658.97 KB
An Adobe Acrobat file Nivolumab-and-ipilimumab-metastatic-melanoma-NEJM-2015 435.19 KB
An Adobe Acrobat file Vemurafenib-Metastatic-Melanoma-NEJM-2011 608.93 KB
An Adobe Acrobat file Vemurafenib-Refractory-Melanoma-NEJM-2012 561.42 KB

REGIONAL DISEASE

Filename Size
An Adobe Acrobat file Chesney_TVECIpi_JCO_2017 981.11 KB
An Adobe Acrobat file ILI_Melphalan_TNFa_JCO_2005 398.84 KB
An Adobe Acrobat file Miura_ILI_Melanoma_ASO_2019 1.3 MB
An Adobe Acrobat file TVEC_Melanoma_JCO_2015 408.25 KB

Program Description

  • About the program
  • Research opportunities
  • Meeting and Conferences
  • Journal Club
  • Eligibility and Applications
  • Contact Information
  • Key Presentations
  • Sentinel Articles

Copyright © 2015-2020 Loma Linda University Health. All Rights Reserved.
Site developed and maintained by Zhappo Studios

Back to top